Lissun Secures Rs 48 Crore in Series A Funding to Revolutionize Pediatric Mental Health
In a significant boost for the Indian health-tech landscape, Gurugram-based startup Lissun has successfully closed a Rs 48 crore Series A funding round. The company, which has carved a niche for itself by focusing on children with special needs and developmental delays, is set to utilize this fresh capital to scale its operations and enhance its specialized care delivery model.
The funding round was led by Colossa Ventures, reflecting growing investor confidence in the startup’s mission to address the critical gaps in pediatric developmental healthcare. The round also saw participation from a robust syndicate of investors, including Physis Capital, RPSG Capital Ventures, Ivycap Ventures, Rainmatter, Multiply Ventures, SucSEED Ventures, New Age India Fund, and Beyond Capital Ventures. This diverse backing underscores the widespread recognition of Lissun’s potential to disrupt the single-specialty health-tech space.
Bridging the Gap in Developmental Healthcare
Lissun has distinguished itself by moving beyond general wellness to address the complex, often underserved needs of children facing developmental delays. By integrating technology with clinical expertise, the platform provides a structured, accessible, and empathetic approach to therapy and support. In a country where pediatric mental health and developmental support are often stigmatized or difficult to access, Lissun’s model offers a beacon of hope for families navigating these challenges.
The infusion of capital comes at a pivotal time for the startup. With the support of its new and existing investors, Lissun plans to expand its reach, invest in advanced diagnostic tools, and strengthen its network of specialists. As the health-tech sector in India continues to mature, Lissun’s focus on a high-impact, specialized segment positions it as a company to watch closely in the coming years. By combining compassionate care with scalable technology, the team is well-equipped to set new benchmarks in pediatric health outcomes across the nation.